THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION

被引：0
|
作者：
HIBINO, T [1 ]
OONUMA, M [1 ]
TAKAHASHI, T [1 ]
HORII, I [1 ]
机构：
[1] SHISEIDO RES CTR,YOKOHAMA,JAPAN
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A514 / A514
页数：1
相关论文
共 50 条
  • [31] CHARACTERIZATION OF PHOSPHORYLATED UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) OF A HUMAN CELL-LINE
    KWAAN, HC
    TAKAHASHI, K
    CLINICAL RESEARCH, 1992, 40 (02): : A376 - A376
  • [32] PRESENCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) IN TISSUE-EXTRACTS OF ANTROCHOANAL POLYP
    YAMASHIRO, Y
    NAKAMURA, M
    HUANG, GW
    KOSUGI, T
    LARYNGOSCOPE, 1992, 102 (09): : 1049 - 1052
  • [33] PHYSICAL EXERCISE INDUCES ENHANCEMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN PLASMA
    DOOIJEWAARD, G
    DEBOER, A
    TURION, PNC
    COHEN, AF
    BREIMER, DD
    KLUFT, C
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (01) : 82 - 86
  • [34] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND MALIGNANCY
    DUFFY, MJ
    FIBRINOLYSIS, 1993, 7 (05) : 295 - 302
  • [35] Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator
    Reinartz, J
    Schaefer, B
    Bechtel, MJ
    Kramer, MD
    EXPERIMENTAL CELL RESEARCH, 1996, 223 (01) : 91 - 101
  • [36] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    STASSEN, JM
    BRONSON, R
    COLLEN, D
    MULLIGAN, R
    FIBRINOLYSIS, 1993, 7 : 27 - 28
  • [37] BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE
    CARMELIET, P
    BOUCHE, A
    DECLERCQ, C
    JANSSEN, S
    POLLEFEYT, S
    WYNS, S
    MULLIGAN, RC
    COLLEN, D
    ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 367 - 382
  • [38] DIFFERENTIAL DETECTION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN AND MONKEY PLASMA
    MOLINARI, A
    GIORGETTI, C
    BONOMINI, L
    GERNA, M
    LANSEN, J
    GUREWICH, V
    FIBRINOLYSIS, 1992, 6 (01) : 17 - 26
  • [39] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN VARIOUS DISEASE STATES
    KRUITHOF, EKO
    GUDINCHET, A
    BACHMANN, F
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (01) : 7 - 12
  • [40] INTRAOCULAR PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) LEVELS IN PREMATURE-INFANT EYES
    TRESE, M
    ORGEL, I
    HARTZER, M
    WILLIAMS, GA
    CHAPMAN, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1085 - 1085
12345